Immunohistochemical analysis of B-cell lymphoma -2 in pleomorphic adenoma and mucoepidermoid carcinoma

• 出版年: Dental Research Journal
• 主要な著者: Saede Atarbashi, Maryam Elahi, Mehdi Khani, Vahid Rakhshan
• フォーマット: 論文
• 言語: 英語
• 出版事項: Wolters Kluwer Medknow Publications 2014-01-01
• 主題: B-cell lymphoma-2; mucoepidermoid carcinoma; pleomorphic adenoma; salivary gland tumor
• オンライン･アクセス: http://www.drjjournal.net/article.asp?issn=1735-3327;year=2014;volume=11;issue=2;spage=257;epage=263;aulast=Atarbashi
• ISSN: 1735-3327; 2008-0255

Background: Salivary gland tumors form a major area in the field of oral pathology. B-cell lymphoma -2 (Bcl-2) is an anti-apoptotic gene with up-regulation in various neoplasms. The aim of the present case-control study was to comparatively investigate the expression of Bcl-2 protein in pleomorphic adenoma (PA) and mucoepidermoid carcinoma (MEC) and assess its potential diagnostic role in differentiating these tumors. Materials and Methods: A total of 28 cases (18 specimens of PA [control] and 10 blocks of MEC [case]) were selected for analysis by streptavidin-biotin peroxidase method with antibody against Bcl-2. The percentage of positive cells was calculated from a minimum of 1000 neoplastic cells and H-score was identified (% positive cells × intensity of staining). Data were analyzed using two-way ANOVA, t-test, Spearman, Chi-square and Fisher tests (α = 0.05). Results: bcl-2 expression was shown in 13 cases (71%) of PA and 3 cases (30%) of MEC. In addition, four cases of PA showed strong staining. There was a significant difference between the expression intensity of Bcl-2 in the two tumors (P = 0.048) according to ANOVA. No correlation was observed between Bcl-2 expression with the size and location of tumors (P > 0.05). Conclusion: Bcl-2 expression might be used for differentiating these tumors. Bcl-2 protein was overexpressed in PA compared with MEC. Hence, it seems that unlike what was observed in PA, Bcl-2 probably does not participate in the pathogenesis of MEC.